Overview
Background
David is a passionate and driven scientist with a successful track record in translational commercially focused technical and academic leadership. David has worked in academia and industry at the interface of chemistry, biochemistry and biology. He has successfully designed and developed several oncology nanomedicines and driven them forward into clinical trials.
As Director of the Protein Expression Facility (PEF) within The University of Queensland, David and his team strive to build collaborations and provide excellent service provision with a wide variety of researchers across academia and industry. Through this work we ensure PEF achieves its vision to be a world leader in protein research services and innovative solutions for protein production driving scientific success.
Availability
- Professor David Owen is:
- Available for supervision
Research interests
-
Protein Science
-
Nanotechnology
-
Radiotheranostics
-
Cancer Biology
-
Bioconjugation
Works
Search Professor David Owen’s works on UQ eSpace
1996
Journal Article
Identification of three C20-gibberellins: GA97 (2β-hydroxy-GA53), GA98 (2β-hydroxy-GA44) and GA99 (2β-hydroxy-GA19)
Mander, Lewis N., Owen, David J., Croker, Stephen J., Gaskin, Paul, Hedden, Peter, Lewis, Mervyn J., Talon, Manuel, Gage, Douglas A., Zeevaart, Jan A.D., Brenner, Mark L. and Sheng, Chuxing (1996). Identification of three C20-gibberellins: GA97 (2β-hydroxy-GA53), GA98 (2β-hydroxy-GA44) and GA99 (2β-hydroxy-GA19). Phytochemistry, 43 (1), 23-28. doi: 10.1016/0031-9422(96)00251-8
1996
Journal Article
Synthesis and confirmation of structure of three 13,15β-dihydroxy C-20 gibberellins, GA100, GA101 and GA102, isolated from the seeds of Helianthus annuus L
Owen, David J., Mander, Lewis N., Gaskin, Paul and Macmillan, Jake (1996). Synthesis and confirmation of structure of three 13,15β-dihydroxy C-20 gibberellins, GA100, GA101 and GA102, isolated from the seeds of Helianthus annuus L. Phytochemistry, 42 (4), 921-925. doi: 10.1016/0031-9422(96)00045-3
1996
Journal Article
Structure determination and synthesis of a new gibberellin, GA99, from spinach plants: 2β-hydroxy-GA19
Mander, Lewis N. and Owen, David J. (1996). Structure determination and synthesis of a new gibberellin, GA99, from spinach plants: 2β-hydroxy-GA19. Tetrahedron Letters, 37 (5), 723-726. doi: 10.1016/0040-4039(95)02252-X
1996
Journal Article
Synthesis of gibberellin GA53 and its (17,17-D2)derivative
Mander, Lewis N., Owen, David J. and Twitchin, Bruce (1996). Synthesis of gibberellin GA53 and its (17,17-D2)derivative. Australian Journal of Chemistry, 49 (2), 249-253. doi: 10.1071/ch9960249
1995
Journal Article
3-epi-GA63, antheridiogen in Anemia phyllitidis
Yamauchi, Tadayuki, Oyama, Naomi, Yamane, Hisakazu, Murofushi, Noboru, Schraudolf, Helmut, Owen, David and Mander, Lewis N. (1995). 3-epi-GA63, antheridiogen in Anemia phyllitidis. Phytochemistry, 38 (6), 1345-1348. doi: 10.1016/0031-9422(94)00834-G
1991
Journal Article
2,5-Dithiacyclopentylideneketene and Ethenedithione, S=C=C=S, Generated by Flash Vacuum Pyrolysis
Wentrup C., Kambouris P., Evans R.A., Owen D., Macfarlane G., Chuche J., Pommelet J.C., Cheikh A.B., Plisnier M. and Flammang R. (1991). 2,5-Dithiacyclopentylideneketene and Ethenedithione, S=C=C=S, Generated by Flash Vacuum Pyrolysis. Journal of the American Chemical Society, 113 (8), 3130-3135. doi: 10.1021/ja00008a048
Supervision
Availability
- Professor David Owen is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Supervision history
Current supervision
-
Doctor Philosophy
The Molecular Characterisation of Myeloperoxidase (MPO) and its role in autoimmunity
Principal Advisor
Other advisors: Professor Ranjeny Thomas, Associate Professor Fiona Simpson, Dr Pie Huda
-
Doctor Philosophy
Assessment of Nanomedicine Efficacy and Mechanism using Metabolic Spectroscopic Imaging.
Associate Advisor
Other advisors: Associate Professor Idriss Blakey
-
Doctor Philosophy
mRNA therapies for liver disorders
Associate Advisor
Other advisors: Dr Seth Cheetham
-
Doctor Philosophy
Broad Spectrum Medical Countermeasure development for Organophosphate Compounds
Associate Advisor
Other advisors: Professor Linda Lua
-
Doctor Philosophy
Development of a versatile targeted alpha therapy platform
Associate Advisor
Other advisors: Dr Nick Fletcher, Dr Pie Huda
Media
Enquiries
For media enquiries about Professor David Owen's areas of expertise, story ideas and help finding experts, contact our Media team: